American Journal of Kidney Diseases
Volume 49, Issue 2 , Pages 175-179 , February 2007

CKD: Common, Harmful, and Treatable—World Kidney Day 2007

  • Andrew S. Levey, MD (Editor-in-Chief, American Journal of Kidney Diseases)

      Affiliations

    • Tufts-New England Medical Center, Boston, Massachusetts
    • ,
  • Sharon P. Andreoli, MD (President, American Society of Pediatric Nephrology)

      Affiliations

    • James Whitcomb Riley Hospital for Children, Indianapolis, Indiana
    • ,
  • Thomas DuBose, MD (President, American Society of Nephrology)

      Affiliations

    • Wake Forest University School of Medicine, Winston-Salem, North Carolina
    • ,
  • Robert Provenzano, MD (President, Renal Physicians Association)

      Affiliations

    • St John Hospital & Medical Center, Detroit, Michigan
    • ,
  • Allan J. Collins, MD, FACP (President, National Kidney Foundation)

      Affiliations

    • University of Minnesota, Minneapolis, Minnesota

References 

  1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  2. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  3. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  4. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  5. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—Measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483
  6. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  7. Keith D, Nicholls G, Guillion C, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  8. Go AS, Chertow G, Dongjie F, et al. Chronic kidney disease and risks of death, cardiovascular events and hospitalizations. N Engl J Med. 2006;351:1296–1305
  9. Coca SG, Krumholz HM, Garg AX, Parikh CR. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA. 2006;296:1377–1384
  10. Mann JFE, Gerstein HC, Pogue J, et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2006;134:629–636
  11. Solomon SD, Rice MM, Jablonski KA, et al. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation. 2006;114:26–31
  12. Tonelli M, Moye L, Sacks FM, et al. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med. 2003;138:98–104
  13. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560–2572
  14. American Diabetes Association. Standards of medical care in diabetes—2006. Diabetes Care. 2006;29(suppl 1):S1–S85
  15. Brosius FC, Hostetter TH, Kelepouris E, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: A science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: Developed in collaboration with the National Kidney Foundation. Hypertension. 2006;48:751–755
  16. Kimm SY, Obarzanek E. Childhood obesity: A new pandemic of the new millennium. Pediatrics. 2002;110:1003–1007
  17. US Renal Data System. USRDS 2001 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2001;
  18. Obrador GT, Ruthazer R, Arora P, et al. Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol. 1999;10:1793–1800

PII: S0272-6386(06)01914-7

doi: 10.1053/j.ajkd.2006.12.013

American Journal of Kidney Diseases
Volume 49, Issue 2 , Pages 175-179 , February 2007

Article Tools

* Image Usage & Resolution